The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register

Aim. To study the incidence of comorbidities and their impact on the prognosis in patients with ischemic heart disease (IHD) included into the PROGNOZ IBS Register.Material and methods. Data from the PROGNOZ IBS register of patients diagnosed with IHD using coronary angiography during the reference...

Full description

Saved in:
Bibliographic Details
Main Authors: S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/434
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227944610758656
author S. N. Tolpygina
S. Yu. Martsevich
A. D. Deev
author_facet S. N. Tolpygina
S. Yu. Martsevich
A. D. Deev
author_sort S. N. Tolpygina
collection DOAJ
description Aim. To study the incidence of comorbidities and their impact on the prognosis in patients with ischemic heart disease (IHD) included into the PROGNOZ IBS Register.Material and methods. Data from the PROGNOZ IBS register of patients diagnosed with IHD using coronary angiography during the reference hospitalization (n=541; 432 male and 109 female) was included in the analysis. 504 (93%) patients were included in the survival analysis. Risk factors of cardiovascular diseases, associated with atherosclerosis, or those that were complications of IHD were considered as comorbidities as well as not cardiovascular diseases – chronic obstructive pulmonary disease, bronchial asthma andchronic kidney disease (CKD).Results. The average duration of follow-up was 7.3±2.19 years. The average number of comorbidities in patients with IHD was 1.83. Comorbidities worsened the prognosis of life: the presence of diabetes mellitus (DM) increased the relative risk (RR) of primary endpoint occurrence by 1.7 times, the combination of DM with hypertension – by 2.4 times, a history of stroke – by 2.3 times (p<0.05); 2 and 3 heart diseases – respectively, by 2.3 and 3.2 times (p<0.05); a combination of chronic lung diseases and CKD stages 3-5 – by 1.4 times (p=0.06); the presence of 2, 3, 4 and 5 comorbidities – respectively, by 4, 5, 6.4 and 13 times (p<0.001). The risk of death from all causes was determined by the number of concomitant cardiovascular diseases: 2 diseases increased RR by 2.3 times, 3 diseases – by 4.6 times, a combination of any 4 diseases – by 3.5 times, of 5 diseases – by 5 times (p<0.05).Conclusion. Prognosis of life in IHD patients is worsened by the presence of several comorbidities: risk factors of cardiovascular disease (DM and hypertension), cardiovascular diseases associated with atherosclerosis or those that are complications of IHD, chronic lung diseases and CKD.
format Article
id doaj-art-7dcbb852878d4bbc80ee32bb844e8a17
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2015-12-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-7dcbb852878d4bbc80ee32bb844e8a172025-08-23T10:00:19ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-0111657157610.20996/1819-6446-2015-11-6-571-576434The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS registerS. N. Tolpygina0S. Yu. Martsevich1A. D. Deev2State Research Centre for Preventive Medicine. Petroverigsky per. 10, Moscow, 101990 RussiaState Research Centre for Preventive Medicine. Petroverigsky per. 10, Moscow, 101990 RussiaState Research Centre for Preventive Medicine. Petroverigsky per. 10, Moscow, 101990 RussiaAim. To study the incidence of comorbidities and their impact on the prognosis in patients with ischemic heart disease (IHD) included into the PROGNOZ IBS Register.Material and methods. Data from the PROGNOZ IBS register of patients diagnosed with IHD using coronary angiography during the reference hospitalization (n=541; 432 male and 109 female) was included in the analysis. 504 (93%) patients were included in the survival analysis. Risk factors of cardiovascular diseases, associated with atherosclerosis, or those that were complications of IHD were considered as comorbidities as well as not cardiovascular diseases – chronic obstructive pulmonary disease, bronchial asthma andchronic kidney disease (CKD).Results. The average duration of follow-up was 7.3±2.19 years. The average number of comorbidities in patients with IHD was 1.83. Comorbidities worsened the prognosis of life: the presence of diabetes mellitus (DM) increased the relative risk (RR) of primary endpoint occurrence by 1.7 times, the combination of DM with hypertension – by 2.4 times, a history of stroke – by 2.3 times (p<0.05); 2 and 3 heart diseases – respectively, by 2.3 and 3.2 times (p<0.05); a combination of chronic lung diseases and CKD stages 3-5 – by 1.4 times (p=0.06); the presence of 2, 3, 4 and 5 comorbidities – respectively, by 4, 5, 6.4 and 13 times (p<0.001). The risk of death from all causes was determined by the number of concomitant cardiovascular diseases: 2 diseases increased RR by 2.3 times, 3 diseases – by 4.6 times, a combination of any 4 diseases – by 3.5 times, of 5 diseases – by 5 times (p<0.05).Conclusion. Prognosis of life in IHD patients is worsened by the presence of several comorbidities: risk factors of cardiovascular disease (DM and hypertension), cardiovascular diseases associated with atherosclerosis or those that are complications of IHD, chronic lung diseases and CKD.https://www.rpcardio.online/jour/article/view/434comorbiditiesregistercoronary heart diseaselong-term prognosis
spellingShingle S. N. Tolpygina
S. Yu. Martsevich
A. D. Deev
The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register
Рациональная фармакотерапия в кардиологии
comorbidities
register
coronary heart disease
long-term prognosis
title The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register
title_full The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register
title_fullStr The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register
title_full_unstemmed The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register
title_short The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register
title_sort influence of concomitant diseases on a long term prognosis in patients with chronic ischemic heart disease according to the prognoz ibs register
topic comorbidities
register
coronary heart disease
long-term prognosis
url https://www.rpcardio.online/jour/article/view/434
work_keys_str_mv AT sntolpygina theinfluenceofconcomitantdiseasesonalongtermprognosisinpatientswithchronicischemicheartdiseaseaccordingtotheprognozibsregister
AT syumartsevich theinfluenceofconcomitantdiseasesonalongtermprognosisinpatientswithchronicischemicheartdiseaseaccordingtotheprognozibsregister
AT addeev theinfluenceofconcomitantdiseasesonalongtermprognosisinpatientswithchronicischemicheartdiseaseaccordingtotheprognozibsregister
AT sntolpygina influenceofconcomitantdiseasesonalongtermprognosisinpatientswithchronicischemicheartdiseaseaccordingtotheprognozibsregister
AT syumartsevich influenceofconcomitantdiseasesonalongtermprognosisinpatientswithchronicischemicheartdiseaseaccordingtotheprognozibsregister
AT addeev influenceofconcomitantdiseasesonalongtermprognosisinpatientswithchronicischemicheartdiseaseaccordingtotheprognozibsregister